Stockreport

Kyowa Kirin stops development of skin condition treatment [Yahoo! Finance]

KIRIN HLDGS CO LTD S/ADR  (KNBWY) 
US:NASDAQ Investor Relations: kirinholdings.co.jp/english/ir
PDF The drug, ?called rocatinlimab, is a monoclonal antibody that was being tested to treat skin conditions such as moderate-to-severe ?atopic dermatitis, ?prurigo nodulari [Read more]